Based on the two transgenic lines that were generated and characterized, we found that aP2‐driven expression of constitutively active TLR4 was not sufficient to induce systemic insulin resistance, despite being sufficient to induce elevated inflammation in WAT. This evidence concerns the gene TLR4 and Insulin resistance.